(Q44776054)

English

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys

scientific article published in February 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Human metapneumovirus

object named as

human metapneumovirus

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

11

object named as

Ron A M Fouchier

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Roderick S Tang

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Kutubuddin Mahmood

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Mia Macphail

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jeanne M Guzzetta

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Aurelia A Haller

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hui Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jasmine Kaur

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Heather A Lawlor

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Elizabeth A Stillman

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jeanne H Schickli

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Richard R Spaete

13

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1657-1667

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Analysis of the genomic sequence of a human metapneumovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Detection and differentiation of avian pneumoviruses (metapneumoviruses).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Animal pneumoviruses: molecular genetics and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

A 1-year experience with human metapneumovirus in children aged <5 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Children with respiratory disease associated with metapneumovirus in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Human metapneumovirus infection in Thai children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Characterization of human metapneumoviruses isolated from patients in North America

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Human metapneumovirus in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Human metapneumovirus infections in young and elderly adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Antigenic and genetic variability of human metapneumoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Genetic diversity between human metapneumovirus subgroups

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

A single amino acid substitution in the viral polymerase creates a temperature-sensitive and attenuated recombinant bovine parainfluenza virus type 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Evaluation of attenuation, immunogenicity and efficacy of a bovine parainfluenza virus type 3 (PIV-3) vaccine and a recombinant chimeric bovine/human PIV-3 vaccine vector in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.009

7 January 2021

based on heuristic

inferred from DOI database lookup

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/15705469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived

1 reference

https://pubmed.ncbi.nlm.nih.gov/15705469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone

1 reference

https://pubmed.ncbi.nlm.nih.gov/15705469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence of human metapneumovirus in Australian children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15705469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15705469

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2004.10.009

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44776054&oldid=2040315559"